PeptideDB

(R,S,R)-ML334 ((R,S,R)-LH601A) 1432065-33-2

(R,S,R)-ML334 ((R,S,R)-LH601A) 1432065-33-2

CAS No.: 1432065-33-2

(R,S,R)-ML334 is the inactive isomer of ML334 and could be utilized as a control compound in experiments. ML334 (LH601A)
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

(R,S,R)-ML334 is the inactive isomer of ML334 and could be utilized as a control compound in experiments. ML334 (LH601A) is a potent, cell-permeable (penetrable) activator of NRF2 that acts by inhibiting the Keap1-NRF2 protein interaction. ML334 binds the Keap1 Kelch domain with a Kd of 1μM. ML334 stimulates NRF2 expression and nuclear translocation and induces antioxidant response element (ARE) activity.

Physicochemical Properties


Molecular Formula C26H26N2O5
Molecular Weight 446.50
CAS # 1432065-33-2
Related CAS # ML334;1432500-66-7
Appearance White to off-white solid powder
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


References [1]. Wen X, et al. Activation of NRF2 Signaling in HEK293 Cells by a First-in-Class Direct KEAP1-NRF2 Inhibitor. J Biochem Mol Toxicol. 2015 Jun;29(6):261-6.
[2]. Hu L, et al. Discovery of a small-molecule inhibitor and cellular probe of Keap1-Nrf2 protein-protein interaction. Bioorg Med Chem Lett. 2013 May 15;23(10):3039-43.

Solubility Data


Solubility (In Vitro) DMSO: 100 mg/mL (223.96 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 5 mg/mL (11.20 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 50.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 2: ≥ 5 mg/mL (11.20 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 50.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.2396 mL 11.1982 mL 22.3964 mL
5 mM 0.4479 mL 2.2396 mL 4.4793 mL
10 mM 0.2240 mL 1.1198 mL 2.2396 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.